Will Lewis takes Insmed CEO job
This article was originally published in Scrip
Executive Summary
Insmed Incorporated has named Will Lewis its president and CEO, effective immediately. He succeeds Tim Whitten, who has resigned. Mr Lewis is the former co-founder, president and CFO of Aegerion Pharmaceuticals.